US · Healthcare · Medical Distribution
EPS came in at 1.32 against a street estimate of 1.22 — a beat of 8.2%.
Analysts rate Henry Schein Inc a buy (7 buy, 8 hold, 1 sell out of 16) with an average price target of $89.31.
| Fund | Stake |
|---|---|
| Kohlberg Kravis Roberts & Co LP | 13.74% |
| BlackRock Inc | 6.17% |
| Artisan Partners Limited Partnership | 5.77% |
| Vanguard Capital Management, LLC | 5.64% |
| FMR Inc | 5.02% |
| Amvescap Plc. | 4.29% |
| JPMorgan Chase & Co | 4.01% |
| State Street Corp | 3.84% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 | 2026-07-30 |
| Shareholder vote results · Q2 2026 | 2026-05-22 |
| Quarterly report · Q1 2026 | 2026-05-05 |
| Results announced · Q2 2026 | 2026-05-05 |
| Proxy statement · Q2 2026 | 2026-04-08 |
| Annual report FY2025 | 2026-02-24 |
| Results announced · Q1 2026 | 2026-02-24 |
| Quarterly report · Q3 2025 | 2025-11-04 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Henry Schein Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.